RWE and Patient-Centered Outcomes
Widespread availability of real-world data has enabled the generation of evidence and insights that benefit patients, providers, plans, and industry. When that evidence reflects patient outcomes, it provides an invaluable perspective on the consumer experience. Explore our real-world evidence (RWE) analyses and guidance to support your strategic decisions.
Avalere to Support Boehringer Ingelheim in Outcomes-Based Contracting
Avalere will empower expanded insight and improvement in outcomes for value-based diabetes medications, using Inovalon’s data resources and advanced value-based care platforms.
Promoting Shared Decision Making Around Costs to Improve Value
Avalere and the Robert Wood Johnson Foundation Launch Eight Grants to Improve Cost-of-Care Conversations Between Patients and Clinicians.
Overview of Appropriate Use Criteria for Treating Knee Osteoarthritis
Earlier this year, Avalere led a work group of rheumatology, orthopedic surgery, psychiatry, sports medicine, and primary care clinicians to develop appropriate use criteria for the use of hyaluronic acid (HA) in the treatment of knee osteoarthritis (OA).
Deconstructing the Path to Innovation Adoption
During the last week of October, Avalere invited a select group of innovators to breakfasts in Los Angeles and San Francisco to discuss elements of successful adoption of innovative technologies and models of care.
Avalere Research Recently Published in Home Healthcare Journal
Avalere recently partnered with the Alliance for Home Health Quality and Innovation (AHHQI) to explore the topic of the future of home health care.
Releasing the Draft Avalere/FasterCures Patient-Perspective Value Framework (PPVF) for Public Input
Avalere and FasterCures released the first deliverable of the Patient-Perspective Value Framework (PPVF) Initiative at the annual Partnering for Cures Conference.
Avalere’s Research Team to Present Comparative Effectiveness Research at Cystic Fibrosis Conference
Results from a new Avalere study will be presented Thursday, October 27, at the 30th Annual North American Cystic Fibrosis Conference in Orlando, Florida.
Stakeholders Encourage More Patient Involvement in Value Assessment Process
This summer, the Institute for Clinical and Economic Review (ICER) opened a national call for suggestions on how to improve its value assessment framework. In response, ICER received over 50 comments. On October 4, ICER made 46 of those comment letters public.
Announcing the Avalere/FasterCures Patient-Perspective Value Framework (PPVF) Initiative and the Steering Committee Members
In June 2016, in collaboration with FasterCures, Avalere launched the Patient-Perspective Value Framework (PPVF) Initiative to develop a value framework that appropriately incorporates the patient's perspective on value.
Most Health Plans Do Not Use Existing Value Frameworks to Make Coverage Decisions
The plans are waiting to see how frameworks will evolve and if physicians embrace them before relying on them to decide which prescription drugs to cover.
Webinar: New Alignments in Data-Driven Care Coordination and Access for Specialty Products
Recently we examined the various models of specialty pharmacy integration/ownership and how they result in different care coordination dynamics and access to drugs. Our findings demonstrate real value and opportunities in linking medical and pharmacy data to better support the patient journey with services and tools.
Health Plans Are Interested in Tying Drug Payments to Patient Outcomes
Hepatitis C and Oncology Are Top Therapeutic Area Targets
Key Takeaways from the FasterCures Value Assessment 2.0 Webinar
On June 1, Josh Seidman participated in a panel discussion hosted by FasterCures to discuss Avalere's collaboration with FasterCures to develop a patient-centric value framework.
Christie Teigland Receives AMCP Platinum Award
Christie Teigland, PhD, vice president, Advanced Analytics, recently received the Academy of Managed Care Pharmacy’s (AMCP) prestigious Platinum Award for her research entitled “Association of Socioeconomic and Clinical Factors with Rates of High-Risk Medication Use in Medicare Advantage Plans.”
While Progress Has Been Made, Barriers Still Impede Fully Interoperable Health Information Technology
On behalf of The Pew Charitable Trusts, Avalere conducted research to identify current barriers to interoperability and some of the best potential solutions in the current political and business environments.
Integrating the Patient Perspective into the Development of Value Frameworks
FasterCures and Avalere partner to develop a patient-perspective value framework.
New Analysis Finds Medicare Payments Higher for Episodes Initiated in Hospital Outpatient Departments
A new analysis by Avalere examines differences in Medicare spending for episodes of care before and after cardiovascular imaging, colonoscopy, and evaluation and management services. Avalere applied a risk adjustment methodology to account for differences in patient demographics and patient severity across settings. The findings suggest when care is initiated in the typically higher-paying HOPD setting than in physicians' offices and ambulatory surgical centers, the services that follow also result in higher spending relative to when care is initiated in the office setting.
Key Steps to Improve Patient-Clinician Cost-of-Care Conversations
With growing out-of-pocket spending for care, patients are increasingly interested in knowing, upfront, how much their care will cost them, and how it relates to the quality and appropriateness of their care. Yet, various barriers often prevent these conversations from occurring during routine clinical encounters.
Video: Keys to a Successful Patient Engagement Strategy
How can you position your organization for new payment models that emphasize quality of care over quantity of services performed or therapies sold? Engage patients. In this short video, Josh Seidman, Avalere Payment & Delivery Innovation, defines the key imperatives to creating a successful patient engagement strategy that will bring your organization to the forefront of the industry's transition from fee-for-service to value-based care.
Clarity on How Pharmaceutical Companies Can Communicate Data Could Spur Investment in Evidence Generation
New research from Avalere Health finds that 86% of pharmaceutical companies would invest more in studies to support the development of healthcare economic information if provided additional guidance on their ability to use this evidence with external audiences.